J & J Drug Prevents Heart Attacks At Cost Of Amputated Toes
In a blow to J&J, for every three heart attacks, strokes, or cardiovascular deaths prevented by Invokana, there were two amputations, 71% of them of toes or the lower foot, according to the results of the 10,142-patient study.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Matthew Herper, Forbes Staff Tags: NYSE:JNJ NYSE:MRK NYSE:LLY Source Type: news
More News: Canagliflozin | Cardiology | Cardiovascular | Heart | Invokana | Pharmaceuticals | Stroke | Study